JP2004504032A5 - - Google Patents

Download PDF

Info

Publication number
JP2004504032A5
JP2004504032A5 JP2002512384A JP2002512384A JP2004504032A5 JP 2004504032 A5 JP2004504032 A5 JP 2004504032A5 JP 2002512384 A JP2002512384 A JP 2002512384A JP 2002512384 A JP2002512384 A JP 2002512384A JP 2004504032 A5 JP2004504032 A5 JP 2004504032A5
Authority
JP
Japan
Prior art keywords
polypeptide
pharmaceutical composition
sep
activity
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002512384A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004504032A (ja
Filing date
Publication date
Priority claimed from GBGB0017387.2A external-priority patent/GB0017387D0/en
Application filed filed Critical
Publication of JP2004504032A publication Critical patent/JP2004504032A/ja
Publication of JP2004504032A5 publication Critical patent/JP2004504032A5/ja
Pending legal-status Critical Current

Links

JP2002512384A 2000-07-14 2001-07-16 性的機能不全の処置用の新規なヒト可溶性分泌エンドペプチダーゼ(sep) Pending JP2004504032A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0017387.2A GB0017387D0 (en) 2000-07-14 2000-07-14 Novel enzyme
PCT/IB2001/001263 WO2002006492A1 (en) 2000-07-14 2001-07-16 A novel human soluble secreted endopeptidase (sep) for the treatment of sexual dysunfction

Publications (2)

Publication Number Publication Date
JP2004504032A JP2004504032A (ja) 2004-02-12
JP2004504032A5 true JP2004504032A5 (https=) 2005-02-24

Family

ID=9895717

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002512384A Pending JP2004504032A (ja) 2000-07-14 2001-07-16 性的機能不全の処置用の新規なヒト可溶性分泌エンドペプチダーゼ(sep)

Country Status (8)

Country Link
US (1) US6878529B2 (https=)
EP (1) EP1303619A1 (https=)
JP (1) JP2004504032A (https=)
AU (1) AU2001269371A1 (https=)
CA (1) CA2415557A1 (https=)
GB (1) GB0017387D0 (https=)
MX (1) MXPA03000426A (https=)
WO (1) WO2002006492A1 (https=)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020086405A1 (en) * 2000-09-25 2002-07-04 Inmaculada Silos-Santiago 56638, a novel human neprilysin protease and uses thereof
ES2310527T3 (es) * 1999-11-19 2009-01-16 Solvay Pharmaceuticals B.V. Enzimas humanas de la familia de las metaloproteasas.
US6650943B1 (en) 2000-04-07 2003-11-18 Advanced Bionics Corporation Fully implantable neurostimulator for cavernous nerve stimulation as a therapy for erectile dysfunction and other sexual dysfunction
GB0017387D0 (en) * 2000-07-14 2000-08-30 Pfizer Ltd Novel enzyme
US6991916B2 (en) * 2000-07-14 2006-01-31 Pfizer Inc. Compounds for the treatment of sexual dysfunction
US20020091129A1 (en) * 2000-11-20 2002-07-11 Mitradev Boolell Treatment of premature ejaculation
US6885895B1 (en) * 2001-04-26 2005-04-26 Advanced Bionics Corporation Methods and systems for electrical and/or drug stimulation as a therapy for erectile dysfunction
AR039352A1 (es) * 2001-05-18 2005-02-16 Solvay Pharm Gmbh Uso de un compuesto que tiene actividad inhibitoria combinada y concurrente con endopeptidasa neutra y metaloproteasa igs5.
US7262184B2 (en) 2003-09-26 2007-08-28 Solvay Pharmaceuticals Gmbh Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
US7452875B2 (en) 2003-09-26 2008-11-18 Solvay Pharmaceuticals Gmbh Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
US7427611B2 (en) 2003-09-26 2008-09-23 Solvay Pharmaceuticals Gmbh Amidomethyl-substituted 1-(carboxyalkyl)-cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
WO2005112939A1 (en) * 2004-05-14 2005-12-01 Solvay Pharmaceuticals Gmbh Medicaments containing dually acting inhibitors of neutral endopeptidase and of human soluble endopeptidase for the treatment of sexual dysfunction
US20050267124A1 (en) * 2004-05-14 2005-12-01 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous producing system and PDEV inhibiitors
US20050267072A1 (en) * 2004-05-14 2005-12-01 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions containing dually acting inhibitors of neutral endopeptidase for the treatment of sexual dysfunction
JP4940135B2 (ja) * 2004-05-17 2012-05-30 ギブン イメージング リミテッド 生体内生検のための方法、システムおよびデバイス
US8622991B2 (en) 2007-03-19 2014-01-07 Insuline Medical Ltd. Method and device for drug delivery
US9220837B2 (en) 2007-03-19 2015-12-29 Insuline Medical Ltd. Method and device for drug delivery
MX2009010000A (es) 2007-03-19 2010-03-17 Insuline Medical Ltd Dispositivo para el suministro de farmaco.
US8409133B2 (en) 2007-12-18 2013-04-02 Insuline Medical Ltd. Drug delivery device with sensor for closed-loop operation
CA2743027C (en) 2008-11-07 2016-04-12 Insuline Medical Ltd. Device and method for drug delivery
WO2010134074A1 (en) * 2009-05-19 2010-11-25 Neuroderm Ltd Compositions for continuous administration of dopa decarboxylase inhibitors
EP2640358B1 (en) 2010-11-15 2018-01-03 Neuroderm Ltd Continuous administration of l-dopa, dopa decarboxylase inhibitors, catechol-o-methyl transferase inhibitors and compositions for same
WO2013025261A2 (en) * 2011-04-06 2013-02-21 Georgia Tech Research Corporation Fluorogenic peptide probes and assays
US9375202B2 (en) 2012-05-04 2016-06-28 Given Imaging Ltd. Device and method for in vivo cytology acquisition
PL2854764T3 (pl) 2012-06-05 2019-07-31 Neuroderm Ltd Kompozycje zawierające apomorfinę i kwasy organiczne oraz ich zastosowania
US10258585B2 (en) 2014-03-13 2019-04-16 Neuroderm, Ltd. DOPA decarboxylase inhibitor compositions
ES2967693T3 (es) 2014-03-13 2024-05-03 Neuroderm Ltd Composiciones del inhibidor de la dopa descarboxilasa
CN112546453B (zh) * 2020-10-15 2022-11-29 西安蓝极医疗电子科技有限公司 基于激光照射治疗男性勃起功能障碍的发光体组件及装置
US11213502B1 (en) 2020-11-17 2022-01-04 Neuroderm, Ltd. Method for treatment of parkinson's disease
US11844754B2 (en) 2020-11-17 2023-12-19 Neuroderm, Ltd. Methods for treatment of Parkinson's disease
US11331293B1 (en) 2020-11-17 2022-05-17 Neuroderm, Ltd. Method for treatment of Parkinson's disease
US12161612B2 (en) 2023-04-14 2024-12-10 Neuroderm, Ltd. Methods and compositions for reducing symptoms of Parkinson's disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2777291B1 (fr) * 1998-04-08 2000-07-07 Inst Nat Sante Rech Med Nouvelle metalloprotease membranaire nep ii et son utilisation pour le criblage d'inhibiteurs utiles en therapie
CA2260376A1 (en) 1999-02-11 2000-08-11 Universite De Montreal New metalloproteases of the neprilysin family
EP1069188A1 (en) 1999-07-15 2001-01-17 Sanofi-Synthelabo Three neprilysin-like membrane metallopeptidases
GB0017387D0 (en) * 2000-07-14 2000-08-30 Pfizer Ltd Novel enzyme

Similar Documents

Publication Publication Date Title
JP2004504032A5 (https=)
MXPA03000426A (es) Una endopeptidasa secretada soluble humana novedosa para el tratamiento de disfuncion sexual.
JP2020200332A5 (https=)
CA2529179A1 (en) Recombinant adeno-associated virus vector for treatment of alzheimer disease
RU2008136324A (ru) Желудочно-кишечный пролиферативный фактор и его применения
JP2004536077A5 (https=)
MX2012008999A (es) Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
MX342291B (es) Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
MXPA01007956A (es) Polipeptido antimicrobiano/neutralizador de endotoxina.
JP2012530504A5 (https=)
HRP20160798T1 (hr) Rekombinantni antigeni iz rsv
JP2010522540A5 (https=)
JP2011528895A5 (https=)
JP2006506942A5 (https=)
MX2008009493A (es) Peptido novedoso y uso del mismo.
WO2000011000A3 (en) New compounds
UA91820C2 (ru) Терапевтическое применение вариантов хемокинов
EP2114431A4 (en) COMPOSITION WITH ARAZYM FOR THE PREVENTION AND TREATMENT OF CANCER
WO2000010999A3 (en) New compounds
JP2004527452A5 (https=)
DE60332425D1 (de) 5t4-antigen-peptidepitope der mhc klasse ii
JP2011507498A5 (https=)
UA83989C2 (ru) Выделенный пептид, который стимулирует противоопухолевый иммунный ответ, фармацевтическая композиция на его основе и ее применение
JP2008531463A5 (https=)
WO2002030979A3 (en) Polypeptides homologous to thymosin, ephrin a receptors, and fibromodulin, and polynucleotides encoding same